Arecor Therapeutics plc
Arecor is a biopharmaceutical company that develops medicines for diabetes and other chronic conditions using its Arestat™ technology platform.
- Differentiated biosimilars
- Arestat™ technology platform
- Ultra-Rapid Acting Insulin (AT247)
- Thermostable vaccines and therapeutics
- Ultra-Concentrated Ultra-Rapid Acting Insulin (AT278)
Locations
Digital Popularity
Social Media
LinkedIn3,299 Followers
Competitors
CHAIN Biotech develops oral vaccines and immuno-therapies targeting the lower gastrointestinal tract, with several therapeutic candidates in pre-clinical development.
Company Details
Arecor Therapeutics plc is operated by Arecor Therapeutics Plc and is a Active company incorporated on 13 April 2021 with the registered office located in Saffron Walden, Essex. Arecor Therapeutics Plc was registered 4 years ago.
Status
Active
Size
Small
Directors
11
Age
4 years old
Employees
44
Turnover
£5.05M
Total Assets
£8.72M
Cash in Bank
£3.24M
Total Liabilities
-£3.37M
Teams
31
11
8
8
7
6
4
Vice President Of Development • Joined Apr 2020
Chief Executive Officer • Joined May 2015
Non Executive Director • Joined Sep 2017
Non Executive Director • Joined Jun 2021
Non Executive Director • Joined Jul 2007
Chief Scientific Officer • Joined Aug 2007
Chief Business Officer • Joined Apr 2023
Formulation Lead • Joined Oct 2024
Executive Assistant • Joined Oct 2018
Associate Director • Joined Oct 2024
Chief Executive Officer • Joined May 2015
Chief Business Officer • Joined Apr 2023
Formulation Lead • Joined Oct 2024
Associate Director • Joined Oct 2024
Senior Formulation Lead • Joined Oct 2024
HR Manager • Joined Jan 2022
Office Manager • Joined Aug 2022
Associate Director CMC • Joined Jul 2023
Director Of Quality Assurance • Joined Feb 2021
Quality Leader • Joined Nov 2023
Chief Scientific Officer • Joined Aug 2007
Formulation Chemist • Joined Dec 2021
Senior Scientist • Joined Mar 2022
Senior Scientist • Joined Sep 2022
Senior Scientist
Scientist II • Joined Nov 2024
Scientist 1 • Joined Jul 2023
Formulation Scientist • Joined May 2022
Vice President Of Development • Joined Apr 2020
Chief Executive Officer • Joined May 2015
Non Executive Director • Joined Sep 2017
Non Executive Director • Joined Jun 2021
Non Executive Director • Joined Jul 2007
Chief Scientific Officer • Joined Aug 2007
Chief Business Officer • Joined Apr 2023
Associate Director CMC • Joined Jul 2023
Scientist II, Diabetes And Obesity • Joined Jun 2021
Senior Scientist • Joined Mar 2022
Senior Scientist • Joined Sep 2022
Senior Scientist
Scientist II • Joined Nov 2024
Scientist 1 • Joined Jul 2023
Formulation Scientist • Joined May 2022
Formulation Lead • Joined Oct 2024
Office Manager • Joined Aug 2022
Associate Director CMC • Joined Jul 2023
Director Of Quality Assurance • Joined Feb 2021
Quality Leader • Joined Nov 2023
Team Leader • Joined Aug 2019
Vice President Of Development • Joined Apr 2020
Chief Business Officer • Joined Apr 2023
Associate Director • Joined Oct 2024
Business Development Associate • Joined Jun 2023
View 31 members